Bentley Systems Announces Winners of the 2021 Going Digital Awards in Infrastructure
3.12.2021 00:01:00 EET | Business Wire | Press release
Bentley Systems, Incorporated (Nasdaq:BSY), the infrastructure engineering software company, today announced the winners of the 2021 Going Digital Awards in Infrastructure. The annual awards program recognizes the extraordinary work of Bentley software users advancing infrastructure design, construction, and operations throughout the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211202005219/en/
Bentley Systems Announces Winners of the 2021 Going Digital Awards in Infrastructure (Photo: Business Wire)
Sixteen independent jury panels selected the 57 finalists from nearly 300 nominations submitted by more than 230 organizations from 45 countries encompassing 19 categories. To see the Going Digital Awards in Infrastructure finalists present their projects, click here.
Bentley Systems showcased 19 Going Digital Awards in Infrastructure winners on December 2 during the 2021 Year in Infrastructure and Going Digital Awards virtual event. On the previous day at the virtual event, 22 Founders’ Honorees were recognized, representing organizations or individuals whose undertakings contribute notably to infrastructure advancement and/or environmental/social development goals.
The winners of the 2021 Going Digital Awards in Infrastructure are:
Bridges
New York State Department of Transportation
East 138th Street over the Major Deegan Expressway
New York City, New York, United States
Buildings and Campuses
Volgogradnefteproekt, LLC
High-tech Multifunctional Medical Complex
Yukki, St. Petersburg, Russia
Digital Cities
Hubei International Logistics Airport Co., Ltd., Shenzhen S.F. Taisen Holdings (Group) Co., Ltd., Airport Construction Engineering Co., Ltd.
Ezhou Huahu Airport Project
Ezhou, Hubei, China
Digital Construction
Clark Construction Group, LLC
SeaTac Airport International Arrivals Facility
Seattle, Washington, United States
Geotechnical Engineering
China Water Resources Beifang Investigation, Design and Research Co. Ltd.
Geological Survey of Water Conservancy and Hydropower Engineering
Tibet, China
Land and Site Development
Liaoning Water Conservancy and Hydropower Survey and Design Research Institute Co., Ltd.
Dongtaizi Reservoir Project
Chifeng, Inner Mongolia, China
Manufacturing
WISDRI Engineering & Research Incorporation Limited
Converter-based Continuous Casting Project of Jinnan Steel Phase II Quwo Base Capacity Reduction and Replacement Project
Quwo, Shanxi, China
Mining and Offshore Engineering
Polyus
Construction of the Blagodatnoye Mill-5
Krasnoyarsk, Krasnoyarsk Krai, Russia
Power Generation
Capital Engineering and Research Incorporation Ltd.
The World’s First 60MW Subcritical Blast Furnace Gas Power Generation Project
Changshu, Jiangsu, China
Project Delivery Information Management
Mott MacDonald Systra JV with Balfour Beatty Vinci
HS2 Phase 1 Main Civil Construction Works
London, United Kingdom
Rail and Transit
Network Rail + Jacobs
Transpennine Route Upgrade
Manchester/Leeds/York, United Kingdom
Reality Modeling
HDR
Diablo Dam Digital Twin Modeling
Whatcom County, Washington, United States
Road and Rail Asset Performance
Collins Engineers, Inc.
Stone Arch Bridge Rehabilitation
Minneapolis, Minnesota, United States
Roads and Highways
PT Hutama Karya (Persero)
Trans Sumatera Toll Road Project Section Serbelawan-Pematangsiantar
Pematangsiantar, Sumatera Utara, Indonesia
Structural Engineering
HDR and the PennFIRST Team
The Pavilion at Penn Medicine
Philadelphia, Pennsylvania, United States
Utilities and Communications
PowerChina Hubei Electric Engineering Co., Ltd.
Suixian and Guangshui 80MWp Ground-based Photovoltaic Power Project of Hubei Energy Group
Guangshui, Hubei, China
Utilities and Industrial Asset Performance
Canadian Energy Company
Asset Data Lifecycle Program
Fort McMurray, Alberta, Canada
Water and Wastewater Treatment Plants
Larson & Toubro Construction
Khatan Group of Villages Water Supply Scheme (Surface Water Treatment), UP, India
Khatan, Uttar Pradesh, India
Water, Wastewater and Stormwater Networks
Companhia Águas de Joinville (CAJ)
Contingency Plan to Ensure Supply in the Event of Drought (Joinville-Santa Catarina)
Joinville, Santa Catarina, Brazil
The students winning the Future Infrastructure Star Challenge are:
Judge’s Choice Winner
Elif Gungormus Deliismail
Mini-Modular-Plant for Digitized Sustainable Campus
Izmir Institute of Technology, Turkey
People’s Choice Winner
Rodman Raul Cordova Rodriguez
Innovative Dam and Hydroelectric Project
Pontifical Catholic University of Rio de Janeiro, Brazil
To view the project descriptions and access the images, visit the Going Digital Awards in Infrastructure webpage. Detailed descriptions of all nominated projects will be published in the print and digital versions of Bentley’s 2021 Infrastructure Yearbook in early 2022. To review the past editions of this publication, access Bentley’s Infrastructure Yearbooks.
Watch the executive sessions and the Going Digital Awards finalists’ presentations from the 2021 Year in Infrastructure and Going Digital Awards virtual event on-demand here.
# #
About Bentley Systems
Bentley Systems (Nasdaq:BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, mining, and industrial facilities. Our offerings include MicroStation-based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, Seequent’s leading geosciences software portfolio, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,000 colleagues and generates annual revenues of more than $800 million in 172 countries.
© 2021 Bentley Systems, Incorporated. Bentley, the Bentley logo, AssetWise, iTwin, MicroStation, ProjectWise, and Seequent are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211202005219/en/
Contact information
Press:
Christine Byrne
+1 203 805 0432
Christine.Byrne@bentley.com
Follow us on Twitter:
@BentleySystems
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom